Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention

Prasad, 2013, Slow but steady progress towards understanding peri-procedural myocardial infarction, Eur Heart J, 34, 1615, 10.1093/eurheartj/eht103

Thygesen, 2012, Third universal definition of myocardial infarction, Circulation, 126, 2020, 10.1161/CIR.0b013e31826e1058

Ricciardi, 2001, Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation, Circulation, 103, 2780, 10.1161/hc2301.092121

Selvanayagam, 2005, Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging, Circulation, 111, 1027, 10.1161/01.CIR.0000156328.28485.AD

Herrmann, 2005, Peri-procedural myocardial injury: 2005 update, Eur Heart J, 26, 2493, 10.1093/eurheartj/ehi455

2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143

Grundy, 2004, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E

Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1

Maron, 2010, Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial, J Am Coll Cardiol, 55, 1348, 10.1016/j.jacc.2009.10.062

Investigators, 2011, Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy, N Engl J Med, 365, 2255, 10.1056/NEJMoa1107579

Kinoshita, 2007, Randomized trial of statin administration for myocardial injury: is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention?, Circ J, 71, 1225, 10.1253/circj.71.1225

Herrmann, 2002, Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction, Circulation, 106, 2180, 10.1161/01.CIR.0000037520.89770.5E

Briguori, 2004, Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction, Eur Heart J, 25, 1822, 10.1016/j.ehj.2004.07.017

Pasceri, 2004, Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study, Circulation, 110, 674, 10.1161/01.CIR.0000137828.06205.87

Levine, 2011, 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, J Am Coll Cardiol, 58, e44, 10.1016/j.jacc.2011.08.007

Takano, 2013, Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention, Am J Cardiol, 111, 1688, 10.1016/j.amjcard.2013.02.018

Burke, 1997, Coronary risk factors and plaque morphology in men with coronary disease who died suddenly, N Engl J Med, 336, 1276, 10.1056/NEJM199705013361802

Hong, 2009, Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis, JACC Cardiovasc Imaging, 2, 458, 10.1016/j.jcmg.2008.12.020

Nasu, 2013, Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography, JACC Cardiovasc Interv, 6, 746, 10.1016/j.jcin.2013.02.018

Goldstein, 2011, Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction, Circ Cardiovasc Interv, 4, 429, 10.1161/CIRCINTERVENTIONS.111.963264

Watabe, 2012, Impact of coronary plaque composition on cardiac troponin elevation after percutaneous coronary intervention in stable angina pectoris: a computed tomography analysis, J Am Coll Cardiol, 59, 1881, 10.1016/j.jacc.2012.01.051

1994, Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS), Lancet, 344, 633, 10.1016/S0140-6736(94)92082-6

Falk, 1995, Coronary plaque disruption, Circulation, 92, 657, 10.1161/01.CIR.92.3.657

Puato, 2010, Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy, Stroke, 41, 1163, 10.1161/STROKEAHA.110.580811

Schartl, 2001, Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease, Circulation, 104, 387, 10.1161/hc2901.093188

Takarada, 2010, The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound, JACC Cardiovasc Interv, 3, 766, 10.1016/j.jcin.2010.05.001

Callister, 1998, Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography, N Engl J Med, 339, 1972, 10.1056/NEJM199812313392703

Takano, 2003, Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy, J Am Coll Cardiol, 42, 680, 10.1016/S0735-1097(03)00770-8

Aliabadi, 1997, Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting, Am J Cardiol, 80, 994, 10.1016/S0002-9149(97)00591-2

Arora, 1989, Side branch occlusion during coronary angioplasty: incidence, angiographic characteristics, and outcome, Cathet Cardiovasc Diagn, 18, 210, 10.1002/ccd.1810180404

Uetani, 2008, The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation, Eur Heart J, 29, 1714, 10.1093/eurheartj/ehn248

Lee, 2011, Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation, Circ Cardiovasc Interv, 4, 378, 10.1161/CIRCINTERVENTIONS.111.962506

Tanaka, 2009, Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study, Eur Heart J, 30, 1348, 10.1093/eurheartj/ehp122

Bae, 2008, Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study, Heart, 94, 1559, 10.1136/hrt.2007.135822

Lee, 2011, Saphenous vein graft intervention, JACC Cardiovasc Interv, 4, 831, 10.1016/j.jcin.2011.05.014

Silva, 1998, Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein graphs with intracoronary angioscopy in patients with unstable angina, Am Heart J, 136, 156, 10.1016/S0002-8703(98)70196-6

Park, 2013, Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention, Eur Heart J, 34, 1662, 10.1093/eurheartj/eht048

Lim, 1997, Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence, J Am Coll Cardiol, 30, 1461, 10.1016/S0735-1097(97)00347-1

Reiter, 2013, Preinfarction angina reduces infarct size in ST-elevation myocardial infarction treated with percutaneous coronary intervention, Circ Cardiovasc Interv, 6, 52, 10.1161/CIRCINTERVENTIONS.112.973164

Anand, 2007, Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers, J Am Coll Cardiol, 50, 2218, 10.1016/j.jacc.2007.08.032

Skyler, 2009, J Am Coll Cardiol, 53, 298, 10.1016/j.jacc.2008.10.008